Nitric oxide ('NO), a free radical species produced by several mammalian cell types, plays a role in regulation of vascular, neurological and immunological signal transduction and function. The role of 'NO in cytotoxic events is acquiring increased significance. The high rate of production and broad distribution of sites of production of 'NO, combined with its facile direct and indirect reactions with metalloproteins, thiols and various oxygen radical species, assures that 'NO will play a central role in regulating vascular, physiological and cellular homoeostasis, as well as critical intravascular free radical and oxidant reactions. At the same time, there are contradictions as to whether 'NO mediates or limits free-radicalmediated tissue injury, and uncertainty regarding its mechanisms of action. 'NO has been portrayed as a pathogenic mediator during ischaemia-reperfusion, and inflammatory and septic tissue injury. In contrast, cell-, metal-and oxidantinduced lipoprotein oxidation events, as well as hepatic, cerebrovascular, pulmonary and myocardial inflammatory and ischaemia-reperfusion injury studies, show convincingly that stimulation of endogenous 'NO production or exogenous administration of 'NO-donating molecules can serve a protective role by inhibition of often oxidant-related mechanisms. The final outcome of toxic versus tissue-protective reactions of 'NO will depend on several factors, including sites and relative concentrations of individual reactive species and their diffusion distances. The following sections address these issues and conclude with a proposal as to how *NO serves as a central regulator of oxidant reactions and diverse free radical-related disease processes.
endothelial-derived relaxation factor, EDRF [I] . Nitric oxide is synthesized by the oxidation of L-arginine to L-citrulline by nitric oxide synthases (NOSs), with both constitutive (cNOS) and inducible (iNOS) forms of NOS reported [2] . Nitric oxide has proven to be a ubiquitous signal transduction molecule and a potent mediator of tissue injury because of its low molecular mass, volatility, lipophilicity, free radical nature and diverse reactivities. Owing to its chemical nature, .NO is an active participant in tissue free radical reactions, readily reacting with partially reduced oxygen species [;.e. superoxide anion ( 02.-) and organic-derived free radicals]. Nitric oxide has a relatively low reactivity for a free radical species, resulting in a long biological half-life (tlI2 = 5-30 s); however, Kelm and Schrader [3] have reported the half-life of *NO in vivo to be considerably shorter (-0.1 s). Nitric oxide and oxygen closely resemble each other in diffusivity, with 'NO slightly less lipophilic, resulting in a greater apparent rate of 'NO diffusion in protein and lower apparent rate of *NO diffusivity in lipid, both relative to oxygen
The high rate of production and broad distribution of sites of production of 'NO, combined with its facile direct and indirect reactions with metalloproteins, thiols and various oxygen radical species, assures that 'NO will play a central role in regulating vascular physiological and cellular homoeostasis as well as critical intravascular free radical and oxidant reactions. It thus becomes evident that reactive species and their reactions with each other play important roles in diverse pathogenic as well as tissue-protective aspects of vascular disease. From this, the following questions arise. What role does 'NO and its myriad of secondary oxygen radical reactions play in the pathology of atherosclerosis and other vascular disease or injury processes such as ischaemia-reperfusion phenomena? Does 'NO always act as a pro-oxidant, via its reaction with 02*-? Can 'NO sometimes be tissueprotective during vascular disease/injury processes (all of which are already established to include enhanced rates of production of reactive oxygen species and oxidant injury in their pathogenesis)?
Reactivity and cellular targets of nitric oxide
The toxicity of 'NO in cell-mediated immune reactions was initially attributed to direct 'NO reaction with thiol-and iron-sulphur-containing mitochondrial enzymes [5] and the inhibition of D N A synthesis via inactivation of the non-haem iron enzyme ribonucleotide reductase [6] . Since tissue 'NO concentrations are generally low ( < I yM), it is important to note concepts derived from studies in vitro may not lend insight into events in vivo. In fact, 'NO reactivity with haem-, iron-sulphur-and thiol-containing proteins often require very high concentrations of 'NO, which may not be achievable in biological systems.
A critical reaction that 'NO undergoes in oxygenated biological media is a direct bimolecular reaction with superoxide anion ( 02'-), yielding peroxynitrite (ONOO-) at almost diffusion-limited rates (6.7 x IO9 M-l-s-') [7] . Thus, ONOO-formation represents a major potential pathway of 'NO reactivity which depends on tissue rates of both 'NO and 02*-production. Peroxynitrite has a half-life of < 1 s under physiological conditions, due to proton-catalysed decomposition and target molecule reactions [SI. To date, it has been shown using pure preparations of ONOO-that this species is a potent oxidant capable of directly oxidizing protein and non-protein sulphydryls [9, 10] . This process is mediated by both one-and two-electron transfer reactions, representing a major pathway of biological ONOO-reactivity. Thiols readily react with other oxidants as well, including 'OH, H202, 02'-and nitrogen dioxide ('NO,) [9, 11] . While 'NO, and ONOO-react efficiently with thiols, 'NO does not at neutral pH. Low yields of S-nitrosylated thiol products are also generated following ONOOreaction with sulphydryl compounds. The formation of peroxynitrous acid (ONOOH) from ONOO-yields a species with unique 'OH--like reactions (i.e.
stimulation of membrane lipid peroxidation) via metal-independent mechanisms [8, 12] . Peroxynitrite is also capable of reaction with metal centres to yield a species with the reactivity of nitronium cation (NO,+), an oxidizing and nitrating intermediate [13] .
It is apparent that ONOO-can serve as a mediator in oxidative actions originally attributed to 'NO or other oxygen-derived species. Nitric oxide will potentiate 02'--mediated tissue damage and leads to ONOO-formation, which can represent a major pathway of 'NO reactivity. Peroxynitrite is now being revealed to be a key contributing reactive species in pathological events associated with stimulation of tissue production of 'NO, i.e. systemic hypotension, inhibition of intermediary metabolism, ischaemia-reperfusion injury, immune complexstimulated pulmonary oedema, cytokine-induced oxidant lung injury and inflammatory cell-mediated pathogen killing/host injury [14-171. While many studies of ONOO-reactivity have, to date, necessarily utilized pure preparations of O N O O -, it is clear that the concurrent presence of other reactive species such as 0,'-and 'NO will dramatically affect the reaction pathways of ONOO-. Thus, as we translate insights from in vitro studies into mechanisms of disease, model systems must be designed to better reflect biological conditions.
Protective effects of nitric oxide
Despite the evidence that the co-generation of 02'-and 'NO often leads to cytotoxic events via direct toxic reactions, as well as from the generation of secondary products such as ONOO-, there are a growing number of observations indicating that 'NO can sometimes serve a protective role in pathological events associated with excess production and reactions of partially reduced oxygen species. Numerous studies of cell or metal-induced lipoprotein oxidation reactions, as well as hepatic, cerebrovascular, splanchnic, pulmonary and myocardial inflammatory and ischaemia-reperfusion injury studies have recently shown that stimulation of endogenous 'NO production or exogenous administration of 'NO often inhibits oxidant-related mechanisms and blunts the ultimate expression of tissue injury at both molecular and functional levels [18-311. In some of these models, inhibition of 'NO synthesis enhanced injury, again emphasizing the salutary role often observed for *NO in oxidant injury-related processes.
Nitric oxide-oxygen radical interactions in at herosclerosis
Mechanisms of low-density lipoprotein (LDL) oxidation Recent evidence now compellingly reveals that reactive oxygen species are central mediators of the initiation and progression of both the structural and functional lesions characteristic of atherosclerosis. In fact, oxidation of LDL, a critical event in the initiation of atheroma formation, is associated with enhanced cellular production of 02'- [32] . LDL is normally incorporated by cells via receptor-mediated endocytosis [33] . Oxidation of LDL by 02*-or other reactive species reduces the affinity of LDL for this uptake mechanism. Consequently, macrophages and other cell types incorporate oxidized LDL via an acetylated-LDL or 'scavenger' receptor, leading to the formation of lipid-engorged foam cells. Oxidized lipoproteins can also promote direct vascular injury through the formation of lipid hydroperoxides within the LDL particle [34] . This event then initiates radical chain oxidation reactions of unsaturated LDL lipids, yielding additional anionic modified lipoprotein species with increased affinity for lipoprotein scavenger receptors.
While the in vivo mechanism of LDL oxidation remains controversial, information from several in vitro systems show that reactive species known to be present in the vascular compartment [02'-, 'OH, ONOO-, peroxyl radical (LOO') generators, copper ion, haem proteins and phospholipases] can readily contribute to oxidative mechanisms. Cell types including monocytes/macrophages, endothelial cells, smooth muscle cells and platelets have all been proposed to serve as sources of these reactive species. The observation that LDL may be oxidatively modified by incubation with soybean lipoxygenase and phospholipase A2 [35] , coupled with data showing that lipoxygenase inhibitors prevent LDL oxidation by endothelial cells or macrophages, suggest that cellular lipoxygenases are critically involved in oxidative modification of LDL. The presence of increased 15-lipoxygenase mRNA and protein mass in macrophage-rich atherosclerotic lesions of humans and Watanabe heritable hyperlipidaemic rabbits also supports this contention [36] .
Peroxidation of lipoprotein lipids, no matter how the mechanism of initiation occurs, proceeds via free radical-mediated chain propagation reactions. These reactions serve to modify several properties of LDL, including electrophoretic mobility, fatty acid peroxide and thiobarbituric acid-reactive material content, the extent of apoprotein amino acid oxidation, polypeptide chain scission of apolipoprotein B and ultimately, the increased uptake, degradation and accumulation of modified LDL by macrophages [34] . The oxidation of LDL can be enhanced by transition metals such as iron or copper, via promotion of propagation reactions through the transition metal-mediated decomposition of endogenous lipoprotein lipid hydroperoxides to LOO' and alkoxyl radical species (LO'). Existing 'seeded' lipoprotein and vascular cell lipid hydroperoxides ( L O O H ) play a key role in these oxidative processes and their consequences, by giving rise to a variety of reactive radical species [;.e. lipid peroxyl (LOO') or alkoxyl (LO') radicals] and secondary breakdown products (i.e. reactive aldehydes) which will react with primary amines to yield fluorescent Schiff's base products [37] . This resultant oxidized lipoprotein product is the more anionic species which becomes a ligand recognized by macrophage scavenger receptor( s) .
Nitric oxide in lipid and lipoprotein oxidation
Nitric oxide has been observed to play a critical role in regulating lipid and In contrast, other data suggest that 'NO production is actually enhanced in hypercholesterolaemic vessels [53].
Superoxide dismutase (SOD), an endogenous scavenger of 02'-, has been used experimentally to limit cellular 02'-concentrations (thus ONOO-formation from 'NO) in an attempt to restore normal *NO-mediated vessel responses. Exogenous administration of native SOD showed little protective effect towards the impaired relaxation response of vessel ring segments from cholesterol-fed rabbits (Fig. 2) . Native SOD, which is relatively membrane-impermeable due to its net negative charge at p H 7.4, is electrostatically repelled from cell membranes. Alternate means to target the delivery of S O D to potential intracellular sites of free radical injury have been developed. We have shown [43] that intravenous injection of liposome-entrapped SOD (Lip-SOD) restores 'NO-mediated relaxation responses in cholesterol-fed rabbits (Fig. 2) . A 2-3-fold increase in intracellular SOD enzymic activity was associated with Lip-SOD treatment in these animals. Additionally, poly(ethy1ene glycol) -derivatized SOD (PEG-SOD) has been used to enhance vascular endothelial antioxidant enzyme levels in hypercholesterolaemic rabbits, yielding similar improvement in 'NO-mediated relaxation [54] . Treatment of vessels with oxypurinol, an inhibitor of xanthine oxidase, also facilitates 'NO-dependent relaxation in this model [55] . These different approaches to restoration of EC-dependent relaxation all involve reducing steadystate concentrations of oxygen radical species, suggesting that 02'--mediated injury (and possibly the formation of oxidized lipid species) resulted in a functional modification of 'NO.
Nitric oxide-oxygen radical interactions in reperfusion injury
It has been widely accepted in recent years that enhanced rates of production of reactive oxygen species (02'-, H202, 'OH) occur following both focal and global myocardial ischaemia-reperfusion, as well as during the reperfusion associated with thrombolytic therapy and other forms of interventional recanalization for the treatment of ischaemic syndromes. There have been extensive studies in both animal models and humans to support the view that the excess production of reactive oxygen species contributes to loss of myocardial function and/or tissue necrosis, based on direct measurement of free-radical-reaction by-products as well as from the protective effects lent by exogenous administration of antioxidant enzymes and free radical scavengers.
It has recently been observed that enhanced tissue production of 'NO occurs following reperfusion of both ischaemic brain cortex and myocardium and that inhibitors of 'NO synthesis will protect from myocardial reoxygenation injury.
Both cNOS and iNOS have been reported in human myocardial tissue, first noted after biopsy of right ventricular tissue from patients with dilated cardiomyopathy. Vascular endothelium, as well as other myocardial cells (endocardial endothelium, fibroblasts and vascular smooth cells) are competent to produce 'NO, with greater extents of *NO production expected during events which expose myocardial and vascular tissues to elevated levels of inflammatory stimuli. This includes vessel injury induced by balloon angioplas ty, exposure of myocytes to macrophagederived soluble inflammatory mediators and macrophage accumulation at sites of vascularized allograft rejection. From in vitro studies, it is also apparent that some cell types, such as smooth-muscle cells, are capable of generating much greater levels of 'NO than vascular endothelium, and thus must be considered to contribute a more direct role in myocardial 'NO reactions than previously thought. From this, it has been concluded that (a) the free radical injury occurring consequent to reperfusion of ischaemic myocardium came predominantly from the potent oxidizing species formed by the reaction of 02*-with 'NO, and (b) that treatment of tissues with inhibitors of *NO synthesis can induce mild tissue ischaemia, thus 'preconditioning' myocardium for a second more injurious ischaemic assault. Some reports have observed that the earliest anomaly in reperfusion injury is an endothelial dysfunction manifested by a loss of *NO-dependent vasorelaxation, due to formation of and reaction with oxygen radical species, principally 02'- [56] . The stimulation of endogenous 'NO synthesis or addition of exogenous 'NO-donating molecules will thus be therapeutic in platelet-mediated ischaemic syndromes such as unstable angina and coronary thrombosis. The protective effects observed for 'NO with in vivo models of reperfusion injury, when administered as a bolus of nitrosothiol or other 'NO donors, are often ascribed to *NO inhibition of inflammatory cell margination and function [21, 22, 28, 29] . In addition, there is a rapid fall in 'NO levels upon reperfusion, thus augmenting 'NO-mediated signal transduction pathways at the level of cyclic GMP provides a useful pharmacological approach for normalizing vascular function and blood flow in the critical early stages following tissue ischaemia [56] .
The dual role of 'NO in ischaemia-reperfusion injury is postulated to include an initial increased 'NO production, which will be tissue-protective by inducing collateral perfusion, but after a time 'NO formation ceases because of lowered oxygen tension, with oxygen serving a critical role in oxidative deamination of arginine to yield 'NO. Upon reoxygenation, 'NO production again recovers, but now, due to the increased presence of other oxygen free radicals, formation of peroxynitrite can occur, thus potentially contributing to further tissue damage. In brain ischaemia-reperfusion phenomena, 'NO has been reported to serve a protective role by inducing vasodilation and reducing neutrophil/platelet adhesion and aggregation, thus leading to increased blood flow, tissue perfusion and attenuation of the ischaemic insult. Nitric oxide may also protect from ischaemicinduced brain injury by 'NO-mediated down-modulation of N-methyl-D-aspartate ( 
Conclusions
In biological systems where co-generation of multiple reactive species occurs, 'NO will exacerbate oxidant injury via production of the potent oxidant ONOOand can also exert tissue-protective roles. While 'NO will exert apparent antioxidant effects by terminating radical chain propagation reactions of alkoxy1 and peroxyl radicals, it is important to note that (a) when the ratio of the relative rates of 02'-to 'NO production in test systems is less than 1:1, 'NO serves as a pro-oxidant, via formation of the potent oxidant ONOO-, and (b) the products of 'NO termination of lipid radical species are unstable and may mediate a different spectrum of as yet undefined target molecule and pathological reactions.
Thus, 'NO regulates critical lipid and lipoprotein oxidation events, by contributing to the formation of potent secondary oxidants from 02'-, catalysing the redirection of 02*--and H202-mediated cytotoxic reactions to other oxidative pathways, serving as an antioxidant via different mechanisms:
(1) Nitric oxide can act as an inhibitor of radical chain propagation reactions via radical-radical reaction with LOO' and LO', with the formation of nitrogencontaining lipid adducts. These novel lipid oxidation adducts are, in part, organic peroxynitrites and would be expected to occur in vivo when diverse inflammatory and pathological processes give rise to similar combinations of reactive species.
(2) Because 'NO can serve as an iron ligand to form iron-nitrosyl complexes, it has been proposed that 'NO will modulate the pro-oxidant effects of iron and other transition metals, thereby limiting their role in the Haber-Weiss-catalysed formation of 'OH and iron-dependent electron transfer reactions. However, the rate of 'NO reaction with ferrous iron (2 x 10' M-' -s-') is significantly lower than for 'NO reaction with either 02*-or LO' and LOO' radical species. It should be noted that with transition metals, 'NO can exert pro-oxidant effects as well, by reducing ferric iron complexes. The reaction between *NO and 02*-in the vasculature also has the combined effect of eliminating a putative antioxidant ('NO) while at the same time generating a more potent oxidant than 02'-(ONOO-). Since the rate constant for 'NO reaction with LOO' is greater than that for a-tocopherol reaction with LOO' and considering that the sometimes > 1 pM tissue concentrations of 'NO can concentrate in membranes, 'NO could act more readily than (or in concert with) the lipophilic antioxidants a-tocopherol, lycopene, retinyl derivatives and p-carotene as an adjunct antioxidant defence against oxygen radical and lipoxygenase-derived oxidized lipid species. The relative rates of production, sites of production and steady-state concentrations of reactive species, antioxidants and tissue mediators will critically influence the observed apparent toxic or protective effects of 'NO in biological systems. The cellular and anatomical sites of production of 02'-and 'NO, and the dominant operative mechanisms of oxidant damage in tissues at the time of 02'-and 'NO production will also profoundly influence expression of the differential oxidant injury-enhancing and protective effects of 'NO. Development of a better understanding of the physiological roles of 'NO, coupled with detailed insight into 'NO regulation of oxygen radical-dependent reactions and the chemistry of 'NO and ONOO-, should yield a more rational basis for the present and future therapeutic use of inhaled *NO gas mixtures, 'NO donors and inhibitors of NOSs. The recent observations of (a) the extremely fast and direct reactivity of 'NO with oxidizing lipids as well as 02 '-, (b) 38.
39.

40.
41.
42.
43.
44.
45.
46.
47. 48.
49.
50.
51.
52.
